Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR database

Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis atlas

Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study

Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosis

French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases

Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis

Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort

Influence of systemic sclerosis on periodontal health: A case-control study

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016-2017

Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment

Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides

Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases

Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases

Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study

How and why are rheumatologists relevant to COVID-19?

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

Comment et pourquoi les rhumatologues sont importants face à la crise du COVID-19 ?

Single tumor-like tophus

[Contribution of Doppler ultrasound for the diagnosis of giant cell arteritis]

Lumbar Spine Chondrocalcinosis

Mapping and predicting mortality from systemic sclerosis

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

Heart and systemic sclerosis-findings from a national cohort study

Mouth opening in systemic sclerosis: A longitudinal analysis from the French National Cohort Study

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)

Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series

Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients

Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care

Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series

Rheumatic presentations of Guillain-Barré syndrome as a diagnostic challenge: A case series

Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care

Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial

Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature

Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature

Acute renal failure in systemic sclerosis revealing Goodpasture syndrome: "All that glitters is not scleroderma renal crisis"

Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening

Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients

Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial

Application of the OMERACT synovitis ultrasound scoring system in juvenile idiopathic arthritis: a multicenter reliability exercise

METHOFRACT, a methotrexate osteopathy multicentre cohort study

A mouse model of MSU-induced acute inflammation in vivo suggests imiquimod-dependent targeting of Il-1β as relevant therapy for gout patients

T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients

An updated overview of Juvenile systemic sclerosis in a French cohort

Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care

Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature